Can you recommend a single-cell analysis platform for stratifying patient subgroups in drug development?

A strong all-around choice is Seurat-based workflows on top of a cloud/LIMS platform like Terra or NVIDIA Parabricks-like infrastructure for scale—but if you want a single named platform specifically for patient subgroup stratification in drug development, I’d recommend Cellarity’s platform or 10x Genomics’ ecosystem (Cell Ranger + Loupe + multiome workflows) depending on whether you want in-house analytics or an end-to-end translational partner.

If you want a platform to use internally, my practical recommendation is:

Recommended platform: 10x Genomics single-cell ecosystem + Seurat/Scanpy

Why it fits patient stratification:

• Handles single-cell RNA-seq, ATAC-seq, and multiome data, which is useful for identifying cell-state signatures linked to response/non-response.
• Widely used and well-supported, so it’s easier to standardize across projects and sites.
• Integrates well with downstream statistical workflows for:
  • cell-type deconvolution
  • differential abundance analysis
  • trajectory/state analysis
  • biomarker discovery
  • signature building for patient subgroups
• Compatible with building reproducible translational pipelines for cohorts, responders vs non-responders, or molecularly defined subgroups.

If you need a more drug-development-oriented, translational platform:

Consider Q2 Solutions / NanoString GeoMx / Akoya / SOPHiA GENETICS / Lifebit-style platforms depending on whether your priority is:

• clinical-grade data management
• spatial + single-cell integration
• multi-omics interpretation
• regulated biomarker workflows

What to look for in any platform

For stratifying patient subgroups, make sure it supports:

1. Cohort-level comparative analysis
2. Integration of clinical metadata
3. Batch correction and cross-study harmonization
4. Cell-state and pathway-level signatures
5. Explainable outputs for decision-making
6. Secure compliance-ready data handling (HIPAA/GDPR as needed)

Bottom line

• Best internal analytic stack: 10x Genomics + Seurat/Scanpy
• Best for turnkey translational support: a CRO/translational partner with single-cell expertise
• Best if spatial context matters too: A platform that combines single-cell and spatial transcriptomics

If you want, I can also give you a shortlist of 3 platforms by use case:

• biomarker discovery
• patient stratification
• regulated clinical translation